Med Journal August 2021 - Page 8

included FDA recommendations , scientific journals , experience of respected colleagues , and physician-specialty guidelines .
Conclusions
A PGx survey was deployed to obtain a better understanding of the knowledge and educational needs of the ACH prescribers .
The PGx survey showed that prescribing clinicians are interested in the opportunity to provide PGx testing to their patients . Prescribers recognized the need for additional information about PGx and welcome eLearning and specialty-specific educational sessions as alternative means of education . In addition , clinicians are concerned about cost , turnaround time , and efficacy of the test . Of note , a representative sample of younger clinicians ( resident house staff ) responded to the survey , perhaps presenting as a marker for their openness to considering PGx as part of their decision-making process .
Pharmacogenomics is fast becoming a mainstay for the 21st century health care delivery . Clinicians are open to learning more about the promise of PGx and eager to utilize this process to improve the quality of clinical care that they deliver to their patients .
References
1 . MV Relling , WE Evans . Pharmacogenomics in the clinic . Nature . 2015 Oct 15 , 526 ( 7573 ): 343-350 [ doi : 10.1038 / nature15817 ].
2 . L Wang , RM Weinshilboum . Pharmacogenomics : candidate gene identification , functional validation and mechanisms . Human Molecular Genetics . 2008 , Vol 17 , Review Issue 2 [ doi : 10.1093 / hmg / ddn270 ].
3 . Preventable Adverse Drug Reactions : A Focus on Drug Interactions . ( 2018 , March 06 ). https :// www . fda . gov / drugs / drug-interactions-labeling / preventable-adverse-drug-reactions-focus-drug-interactions .
4 . Table of Pharmacogenomic Biomarkers in Drug Labeling . ( 2020 , Aug 18 ). https :// www . fda . gov / drugs / scienceand-research-drugs / table-pharmacogenomic-biomarkers-drug-labeling .
5 . D Mehta , R Uber , T Ingle , C Li , Z Liu , S Thakkar , B Ning , L Wu , J Yang , S Harris , G Zhou , J Xu , W Tong , L Lesko , H Fang . Study of pharmacogenomic information in FDA-approved drug labeling to facilitate application of precision medicine . Drug Discov Today . 2020 May ; 25 ( 5 ): 813-820 . [ doi : 10.1016 / j . drudis . 2020.01.023 ].
6 . PA Harris , R Taylor , R Thielke , J Payne , N Gonzalez , JG Conde . Research electronic data capture ( REDCap ) — A metadata-driven methodology and workflow process for providing translational research informatics support . J Biomed Inform . 2009 Apr , 42 ( 2 ): 377-81 .
7 . PA Harris , R Taylor , BL Minor , V Elliott , M Fernandez , L O ’ Neal , L Mc- Leod , G Delacqua , F Delacqua , J Kirby , SN Duda , REDCap Consortium , The REDCap consortium : Building an international community of software partners . J Biomed Inform . 2019 May 9 [ doi : 10.1016 / j . jbi . 2019 . 103208 ].
8 . Verbrugge RR , Agatep BC , Aubert RE , Epstein RS , Frueh FW . Adoption of pharmacogenomic testing by US physicians : results of a nationwide survey . Clin Pharmacol Ther . 2012 Mar ; 91 ( 3 ): 450-8 . [ doi : 10.1038 / clpt . 2011.306 ].
32 • The Journal of the Arkansas Medical Society www . ArkMed . org